Life-Changing Research
While today’s state-of-the-art labs feature modern, cutting-edge technology and equipment, the goal remains the same as it was 100 years ago: Discovering the best therapies and treatments to preserve and protect vision and eye health for people everywhere.Our founder, William Holland Wilmer, understood that knowledge is key to advancing patient care. This is evident from his insistence that the mission of the Wilmer Ophthalmological Institute include not only clinical care but also research and education.
Wilmer understood that research informs clinical care. It allows us to find what works and what doesn’t work, to understand impacts and limitations, and to identify new questions and promising avenues of study that will, in the end, lead to innovation — to new cures and ways to make life better for our patients and for people everywhere. Wilmer trainees’ exposure to ongoing research equips them with an education that puts them at the forefront in providing the most advanced care for their patients.
-
At The Vanguard
Innovative, collaborative and well-resourced, Wilmer researchers continue to lead the way in the bold quest to cure blinding eye disease.
-
Designer Drugs
The combination of biomaterials engineering and AI-driven drug design offers promising solutions to some of the most pressing challenges in eye care.
-
Keeping Mitochondria Healthy
Investigating molecular pathways that promote cell survival and regeneration — with the goal of preventing AMD before it begins.
-
Confronting Paradoxes
New findings help explain why diabetic patients who start glucose control or have high glycemic variability may experience worsening of diabetic eye disease — and suggest a path to prevention.
-
Faculty Start-Ups
Wilmer researchers and clinicians are working with The Johns Hopkins University and oversight committees to create companies to bring their treatments to market.
